| Product Code: ETC9967281 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) HER2 Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) HER2 Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) HER2 Testing Market - Industry Life Cycle |
3.4 United States (US) HER2 Testing Market - Porter's Five Forces |
3.5 United States (US) HER2 Testing Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.6 United States (US) HER2 Testing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 United States (US) HER2 Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) HER2 Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of breast cancer in the United States |
4.2.2 Growing awareness about personalized medicine and targeted therapies |
4.2.3 Advancements in technology leading to more accurate and efficient HER2 testing |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for new testing methods |
4.3.2 High cost associated with HER2 testing procedures |
4.3.3 Limited access to HER2 testing in certain regions or healthcare settings |
5 United States (US) HER2 Testing Market Trends |
6 United States (US) HER2 Testing Market, By Types |
6.1 United States (US) HER2 Testing Market, By Technique |
6.1.1 Overview and Analysis |
6.1.2 United States (US) HER2 Testing Market Revenues & Volume, By Technique, 2021- 2031F |
6.1.3 United States (US) HER2 Testing Market Revenues & Volume, By Fluorescence In Situ Hybridization, 2021- 2031F |
6.1.4 United States (US) HER2 Testing Market Revenues & Volume, By Dual-Probe, 2021- 2031F |
6.1.5 United States (US) HER2 Testing Market Revenues & Volume, By Single-Probe, 2021- 2031F |
6.1.6 United States (US) HER2 Testing Market Revenues & Volume, By Chromogenic In Situ Hybridization (CISH), 2021- 2031F |
6.1.7 United States (US) HER2 Testing Market Revenues & Volume, By Silver-Enhanced In Situ Hybridization, 2021- 2031F |
6.2 United States (US) HER2 Testing Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) HER2 Testing Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United States (US) HER2 Testing Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.3 United States (US) HER2 Testing Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) HER2 Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) HER2 Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 United States (US) HER2 Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) HER2 Testing Market Import-Export Trade Statistics |
7.1 United States (US) HER2 Testing Market Export to Major Countries |
7.2 United States (US) HER2 Testing Market Imports from Major Countries |
8 United States (US) HER2 Testing Market Key Performance Indicators |
8.1 Adoption rate of HER2 testing in different healthcare facilities |
8.2 Number of research studies and clinical trials focused on HER2 testing technologies |
8.3 Patient outcomes and survival rates following targeted HER2 therapy |
8.4 Rate of reimbursement for HER2 testing procedures |
8.5 Level of investment in research and development for improving HER2 testing methodologies |
9 United States (US) HER2 Testing Market - Opportunity Assessment |
9.1 United States (US) HER2 Testing Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.2 United States (US) HER2 Testing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 United States (US) HER2 Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) HER2 Testing Market - Competitive Landscape |
10.1 United States (US) HER2 Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) HER2 Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here